| Novartis Pharma Schweiz AG - Tyverb, Filmtabletten | | 57937 | | 01 | | Tyverb | | Filmtabletten | | L01EH01 | | Lapatinib | | 23.05.2007 | | |
| | Composition | | lapatinibum 250 mg ut lapatinibi ditosilas monohydricus 405 mg, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto, natrium 2.82 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Lapatinib | 250 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lapatinib | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Sodium | 2.82 mg | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| |
|
